BR112015000147A2 - composição farmacêutica para formação de película para aplicação dérmica - Google Patents
composição farmacêutica para formação de película para aplicação dérmicaInfo
- Publication number
- BR112015000147A2 BR112015000147A2 BR112015000147A BR112015000147A BR112015000147A2 BR 112015000147 A2 BR112015000147 A2 BR 112015000147A2 BR 112015000147 A BR112015000147 A BR 112015000147A BR 112015000147 A BR112015000147 A BR 112015000147A BR 112015000147 A2 BR112015000147 A2 BR 112015000147A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- film forming
- dermal film
- dermal
- forming
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
- B65D83/75—Aerosol containers not provided for in groups B65D83/16 - B65D83/74
- B65D83/752—Aerosol containers not provided for in groups B65D83/16 - B65D83/74 characterised by the use of specific products or propellants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261668846P | 2012-07-06 | 2012-07-06 | |
PCT/EP2013/064301 WO2014006202A1 (en) | 2012-07-06 | 2013-07-05 | A topical composition comprising a film-forming polymer for delivering an active ingredient to skin |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015000147A2 true BR112015000147A2 (pt) | 2017-06-27 |
Family
ID=48747567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015000147A BR112015000147A2 (pt) | 2012-07-06 | 2013-07-05 | composição farmacêutica para formação de película para aplicação dérmica |
Country Status (16)
Country | Link |
---|---|
US (3) | US20150196646A1 (pt) |
EP (2) | EP2900210A1 (pt) |
JP (2) | JP2015521996A (pt) |
KR (2) | KR20150027831A (pt) |
CN (2) | CN104519869A (pt) |
AU (1) | AU2013285409B2 (pt) |
BR (1) | BR112015000147A2 (pt) |
CA (1) | CA2878102A1 (pt) |
HK (2) | HK1208170A1 (pt) |
IL (1) | IL236179A0 (pt) |
IN (1) | IN2014DN11232A (pt) |
MX (1) | MX2014015657A (pt) |
NZ (1) | NZ703574A (pt) |
RU (2) | RU2015104019A (pt) |
WO (2) | WO2014006201A1 (pt) |
ZA (1) | ZA201409276B (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101749514B1 (ko) * | 2010-06-11 | 2017-06-21 | 레오 파마 에이/에스 | 비타민 d 유사체 및 코르티코스테로이드를 포함하는 약제학적 분무 조성물 |
WO2016010988A1 (en) * | 2014-07-14 | 2016-01-21 | Novan, Inc. | Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same |
TW201636025A (zh) * | 2015-04-15 | 2016-10-16 | Maruho Kk | 皮膚用之醫藥組成物 |
WO2017019614A1 (en) | 2015-07-28 | 2017-02-02 | Novan, Inc. | Combinations and methods for the treatment and/or prevention of fungal infections |
US20170296484A1 (en) * | 2015-11-23 | 2017-10-19 | Grace Therapeutics Llc | Topical Film-Forming Spray |
WO2018020385A1 (en) * | 2016-07-27 | 2018-02-01 | Sun Pharmaceutical Industries Limited | Touch-free topical spray of halobetasol |
US20180028767A1 (en) * | 2016-07-27 | 2018-02-01 | Sun Pharmaceutical Industries Limited | Topical spray system of halobetasol |
CN110087652A (zh) | 2016-12-16 | 2019-08-02 | 株式会社钟化 | 甲癣治疗剂 |
TWI655943B (zh) * | 2017-11-22 | 2019-04-11 | 台鉅生技股份有限公司 | 水性痤瘡隔離組成物、透明痤瘡隔離膜及其形成方法 |
US11439986B2 (en) | 2017-12-13 | 2022-09-13 | Scientific Design Company, Inc. | Silver impregnation solution containing high-boiling oxygenated additive and its use in ethylene oxide catalyst preparation |
CN108904445A (zh) * | 2018-08-06 | 2018-11-30 | 江苏知原药业有限公司 | 钙泊三醇纳米悬浮液 |
WO2020161771A1 (ja) * | 2019-02-04 | 2020-08-13 | マルホ株式会社 | 皮膚用組成物 |
CN110038010A (zh) * | 2019-04-28 | 2019-07-23 | 瑞雅科医药(北京)有限公司 | 一种苦味厌恶制剂及其制备方法与防咬笔 |
CN110339184B (zh) * | 2019-08-13 | 2020-05-08 | 哈尔滨乾佰纳生物药业有限公司 | 一种医用修复涂膜剂及其制备方法 |
US20230143793A1 (en) * | 2020-04-02 | 2023-05-11 | Twinmedix Llc | Cosmetic compositions |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2238442A (en) * | 1939-05-25 | 1941-04-15 | Ernest F Drew | Mixed capric-caprylic esters and method of making same |
JP2556075B2 (ja) * | 1987-12-23 | 1996-11-20 | 日産化学工業株式会社 | 消炎鎮痛外用剤 |
HU219480B (hu) * | 1991-05-23 | 2001-04-28 | Novartis Ag. | Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására |
TW247878B (pt) * | 1991-07-02 | 1995-05-21 | Takeda Pharm Industry Co Ltd | |
JP3803393B2 (ja) * | 1994-01-12 | 2006-08-02 | 久光製薬株式会社 | 爪白癬治療用組成物 |
JPH10218793A (ja) * | 1997-02-03 | 1998-08-18 | Nichiban Co Ltd | 経皮吸収型消炎鎮痛用テープ剤及びその製造方法 |
ATE252380T1 (de) * | 1999-02-05 | 2003-11-15 | Cipla Ltd | Topische sprays enthaltend eine filmbildende zusammensetzung |
JP2000281570A (ja) * | 1999-03-30 | 2000-10-10 | Nichiban Co Ltd | 経皮投与用貼付剤 |
US6962691B1 (en) | 1999-05-20 | 2005-11-08 | U & I Pharmaceuticals Ltd. | Topical spray compositions |
US8741332B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for dermally treating neuropathic pain |
US8741333B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for treating dermatitis or psoriasis |
US20070196325A1 (en) | 2004-06-07 | 2007-08-23 | Jie Zhang | Compositions and methods for dermally treating infections |
US20070196452A1 (en) | 2004-06-07 | 2007-08-23 | Jie Zhang | Flux-enabling compositions and methods for dermal delivery of drugs |
US20070189977A1 (en) | 2004-06-07 | 2007-08-16 | Jie Zhang | Spray-on formulations and methods for dermal delivery of drugs |
US20080019927A1 (en) | 2004-06-07 | 2008-01-24 | Jie Zhang | Compositions and methods for dermally treating neuropathy with minoxidil |
US20070196457A1 (en) | 2004-06-07 | 2007-08-23 | Jie Zhang | Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs |
US20070196453A1 (en) | 2004-06-07 | 2007-08-23 | Jie Zhang | Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs |
US20070190124A1 (en) | 2004-06-07 | 2007-08-16 | Jie Zhang | Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs |
US20070189980A1 (en) | 2004-06-07 | 2007-08-16 | Jie Zhang | Compositions and methods for treating alopecia |
US8907153B2 (en) | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
US20070189978A1 (en) | 2004-06-07 | 2007-08-16 | Jie Zhang | Compositions and methods for dermally treating musculoskeletal pain |
US20070196323A1 (en) | 2004-06-07 | 2007-08-23 | Jie Zhang | Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs |
US20070196293A1 (en) | 2004-06-07 | 2007-08-23 | Jie Zhang | Compositions and methods for treating photo damaged skin |
FR2871698B1 (fr) * | 2004-06-17 | 2008-07-04 | Galderma Sa | Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse |
WO2006111426A1 (en) | 2005-04-19 | 2006-10-26 | Galderma S.A. | Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology |
GB0518769D0 (en) | 2005-09-14 | 2005-10-19 | Medpharm Ltd | Topical formulations |
KR20080077625A (ko) * | 2005-11-25 | 2008-08-25 | 페플린 리서치 피티이 리미티드 | 상처 치유 방법 |
AU2006326033A1 (en) * | 2005-12-14 | 2007-06-21 | Zars Pharma, Inc. | Spray-on formulations and methods for dermal delivery of drugs |
EP1800671A1 (de) * | 2005-12-23 | 2007-06-27 | Bayer Schering Pharma Aktiengesellschaft | Verwendung filmbildender Haarpflegepolymere und diese Polymere enthaltenden pharmazeutischen Zubereitungen und Pflaster |
US9393218B2 (en) | 2005-12-23 | 2016-07-19 | Epinamics Gmbh | Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers |
MX2008008211A (es) * | 2005-12-23 | 2008-09-03 | Epinamics Gmbh | Uso de polimeros para el cuidado del cabello formando peliculas del grupo de los poliuretanos y preparaciones farmaceuticas y parches conteniendo estos polimeros. |
US20070280972A1 (en) | 2006-04-25 | 2007-12-06 | Zars, Inc. | Adhesive solid gel-forming formulations for dermal drug delivery |
KR101749514B1 (ko) * | 2010-06-11 | 2017-06-21 | 레오 파마 에이/에스 | 비타민 d 유사체 및 코르티코스테로이드를 포함하는 약제학적 분무 조성물 |
EP2444067A1 (en) * | 2010-10-20 | 2012-04-25 | Laboratorios Ojer Pharma S.L. | Anhydrous gel comprising mupirocin |
-
2013
- 2013-07-05 KR KR1020157003084A patent/KR20150027831A/ko not_active Application Discontinuation
- 2013-07-05 CN CN201380040976.5A patent/CN104519869A/zh active Pending
- 2013-07-05 WO PCT/EP2013/064300 patent/WO2014006201A1/en active Application Filing
- 2013-07-05 BR BR112015000147A patent/BR112015000147A2/pt not_active IP Right Cessation
- 2013-07-05 CA CA2878102A patent/CA2878102A1/en not_active Abandoned
- 2013-07-05 AU AU2013285409A patent/AU2013285409B2/en not_active Ceased
- 2013-07-05 JP JP2015519238A patent/JP2015521996A/ja active Pending
- 2013-07-05 RU RU2015104019A patent/RU2015104019A/ru not_active Application Discontinuation
- 2013-07-05 MX MX2014015657A patent/MX2014015657A/es unknown
- 2013-07-05 EP EP13734410.7A patent/EP2900210A1/en not_active Withdrawn
- 2013-07-05 US US14/410,489 patent/US20150196646A1/en not_active Abandoned
- 2013-07-05 EP EP13737817.0A patent/EP2900211A1/en not_active Withdrawn
- 2013-07-05 JP JP2015519237A patent/JP2015521995A/ja active Pending
- 2013-07-05 KR KR1020157003082A patent/KR20150028840A/ko not_active Application Discontinuation
- 2013-07-05 WO PCT/EP2013/064301 patent/WO2014006202A1/en active Application Filing
- 2013-07-05 CN CN201380036067.4A patent/CN104427973A/zh active Pending
- 2013-07-05 RU RU2015103911A patent/RU2015103911A/ru unknown
- 2013-07-05 US US14/412,978 patent/US9345774B2/en not_active Expired - Fee Related
- 2013-07-05 NZ NZ703574A patent/NZ703574A/en not_active IP Right Cessation
- 2013-07-05 IN IN11232DEN2014 patent/IN2014DN11232A/en unknown
-
2014
- 2014-12-11 IL IL236179A patent/IL236179A0/en unknown
- 2014-12-17 ZA ZA2014/09276A patent/ZA201409276B/en unknown
-
2015
- 2015-09-10 HK HK15108822.0A patent/HK1208170A1/xx unknown
- 2015-09-29 HK HK15109553.3A patent/HK1208812A1/xx unknown
-
2016
- 2016-03-29 US US15/084,210 patent/US20160206629A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MX2014015657A (es) | 2015-03-20 |
EP2900210A1 (en) | 2015-08-05 |
US20150196646A1 (en) | 2015-07-16 |
JP2015521995A (ja) | 2015-08-03 |
AU2013285409A1 (en) | 2015-01-22 |
WO2014006202A1 (en) | 2014-01-09 |
KR20150027831A (ko) | 2015-03-12 |
IL236179A0 (en) | 2015-01-29 |
CN104519869A (zh) | 2015-04-15 |
WO2014006201A1 (en) | 2014-01-09 |
HK1208170A1 (en) | 2016-02-26 |
RU2015104019A (ru) | 2016-08-27 |
US20150157729A1 (en) | 2015-06-11 |
AU2013285409B2 (en) | 2018-03-15 |
JP2015521996A (ja) | 2015-08-03 |
CN104427973A (zh) | 2015-03-18 |
KR20150028840A (ko) | 2015-03-16 |
RU2015103911A (ru) | 2016-08-27 |
IN2014DN11232A (pt) | 2015-10-02 |
EP2900211A1 (en) | 2015-08-05 |
ZA201409276B (en) | 2017-06-28 |
US20160206629A1 (en) | 2016-07-21 |
US9345774B2 (en) | 2016-05-24 |
HK1208812A1 (en) | 2016-03-18 |
NZ703574A (en) | 2016-10-28 |
CA2878102A1 (en) | 2014-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015000147A2 (pt) | composição farmacêutica para formação de película para aplicação dérmica | |
DK3181122T3 (da) | Farmaceutisk dasatinib-sammensætning | |
DK2694038T3 (da) | Farmaceutisk sammensætning | |
DK3030262T3 (da) | Kombineret farmaceutisk sammensætning | |
BR112015000891A2 (pt) | embalagem para seringa | |
BR112014003052A2 (pt) | composições farmacêuticas | |
BR112015004936A2 (pt) | composição farmacêutica revestida contendo regorafenib | |
BR112014032798A2 (pt) | composição | |
ZA201501930B (en) | Pharmaceutical composition | |
CO6930367A2 (es) | Composiciones farmaceúticas | |
DK2897594T3 (da) | Farmaceutisk sammensætning | |
EP2832730A4 (en) | MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION | |
CO6940426A2 (es) | Formulaciones farmacéuticas | |
DK2815752T3 (da) | Oral farmaceutisk sammensætning | |
ES2721400T8 (es) | Composición de Diclofenaco | |
BR112015008572A2 (pt) | formulações de liberação modificada para oprozomib | |
CL2014003283A1 (es) | Formulación farmacéutica. | |
BR112014009319A2 (pt) | compostos farmacêuticos | |
BR112015003116A2 (pt) | preparação farmacêutica sólida contendo levotiroxina | |
BR112014015885A8 (pt) | preparação farmacêutica | |
BR112014032712A2 (pt) | composição | |
BR112015002646A2 (pt) | composto e composição farmacêutica | |
SMT201600419B (it) | Composizione farmaceutica contenente fosfolipidi | |
CU24157B1 (es) | Composición farmacéutica de liberación prolongada de trimetazidina | |
ZA201502987B (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2521 DE 30/04/2019. |